These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12773671)

  • 1. Gadodiamide administration causes spurious hypocalcemia.
    Prince MR; Erel HE; Lent RW; Blumenfeld J; Kent KC; Bush HL; Wang Y
    Radiology; 2003 Jun; 227(3):639-46. PubMed ID: 12773671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements.
    Zhang HL; Ersoy H; Prince MR
    J Magn Reson Imaging; 2006 Mar; 23(3):383-7. PubMed ID: 16463306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    Wiginton CD; Kelly B; Oto A; Jesse M; Aristimuno P; Ernst R; Chaljub G
    AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spurious hypocalcemia after gadodiamide administration.
    Williams SF; Meek SE; Moraghan TJ
    Mayo Clin Proc; 2005 Dec; 80(12):1655-7. PubMed ID: 16342660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudohypocalcemia after magnetic resonance imaging with gadolinium in patients with cirrhosis.
    Kefalas CH; Murray NG; Aguanno JJ; Dockery WD; Weinstein JS; Anderson K; Klintmalm GB
    Liver Transpl; 2004 Jan; 10(1):136-40. PubMed ID: 14755791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower extremity arteriography with use of iodinated contrast material or gadodiamide to supplement CO2 angiography in patients with renal insufficiency.
    Spinosa DJ; Angle JF; Hagspiel KD; Kern JA; Hartwell GD; Matsumoto AH
    J Vasc Interv Radiol; 2000 Jan; 11(1):35-43. PubMed ID: 10693711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic impact of falsely decreased calcium values caused by gadoversetamide interference.
    Gandhi MJ; Narra VR; Brown JJ; Guo A; Grosu DS; Parvin CA; Scott MG
    AJR Am J Roentgenol; 2008 Mar; 190(3):W213-7. PubMed ID: 18287415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of gadodiamide (Gd-DTPA-BMA) in renal 3D-magnetic resonance angiography (MRA): a phase II study.
    Kittner T; Rudolf J; Fages JF; Legmann P; Aschauer M; Repa I; Alvares MR; Savalegui I; Ittrich H; Geterud K; de Kevviler E; Ayuso J; Lockhart ME; Blum A; Iliasch H; Leisinger G; van Beek EJ; Reid AW; Brown JJ; Yu TC; Flamm SD; Düber C; Judmaier W; Reimer P; Stiskal M; Kramann B; Wolff S; Blankenstein C
    Eur J Radiol; 2007 Dec; 64(3):456-64. PubMed ID: 17412546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of nephrotoxicity of gadodiamide in unselected hospitalized patients.
    Trivedi H; Raman L; Benjamin H; Batwara R
    Postgrad Med; 2009 Sep; 121(5):166-70. PubMed ID: 19820286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spurious hypocalcemia after Omniscan- or OptiMARK-enhanced magnetic resonance imaging: an algorithm for minimizing a false-positive laboratory value.
    Emerson J; Kost G
    Arch Pathol Lab Med; 2004 Oct; 128(10):1151-6. PubMed ID: 15387706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection.
    Krause U; Kroencke T; Spielhaupter E; Taupitz M; Kenn W; Hamm B; Hahn D
    J Magn Reson Imaging; 2005 Apr; 21(4):449-54. PubMed ID: 15778953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of single- versus triple-dose gadodiamide injection- enhanced MR angiography of the abdomen: a phase III double-blind multicenter study.
    Thurnher SA; Capelastegui A; Del Olmo FH; Dondelinger RF; Gervás C; Jassoy AG; Keto P; Loewe C; Ludman CN; Marti-Bonmati L; Meusel M; da Cruz JP; Pruvo JP; Sanjuan VM; Vogl T
    Radiology; 2001 Apr; 219(1):137-46. PubMed ID: 11274548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of CO(2)- and gadodiamide-enhanced angiography for the evaluation and percutaneous treatment of renal artery stenosis in patients with chronic renal insufficiency.
    Spinosa DJ; Matsumoto AH; Angle JF; Hagspiel KD; Cage D; Bissonette EA; Koenig KG; Ayers CR; McConnell K
    AJR Am J Roentgenol; 2001 May; 176(5):1305-11. PubMed ID: 11312200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal insufficiency: usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous treatment.
    Spinosa DJ; Matsumoto AH; Angle JF; Hagspiel KD; McGraw JK; Ayers C
    Radiology; 1999 Mar; 210(3):663-72. PubMed ID: 10207465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.
    Collidge TA; Thomson PC; Mark PB; Traynor JP; Jardine AG; Morris ST; Simpson K; Roditi GH
    Radiology; 2007 Oct; 245(1):168-75. PubMed ID: 17704357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of serum calcium concentration after administration of four gadolinium-based contrast agents to human volunteers.
    Brown JJ; Hynes MR; Wible JH
    AJR Am J Roentgenol; 2007 Dec; 189(6):1539-44. PubMed ID: 18029898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrogenic systemic fibrosis: possible association with a predisposing infection.
    Golding LP; Provenzale JM
    AJR Am J Roentgenol; 2008 Apr; 190(4):1069-75. PubMed ID: 18356457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artifactual hypocalcaemia after intravenous administration of gadodiamide (Omniscan).
    Decupere M; Ooms V; Oyen R; Kuypers DR; Claes K
    Nephrol Dial Transplant; 2005 Jul; 20(7):1516-7. PubMed ID: 15886213
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).
    Khurana A; Runge VM; Narayanan M; Greene JF; Nickel AE
    Invest Radiol; 2007 Feb; 42(2):139-45. PubMed ID: 17220732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrogenic systemic fibrosis: risk factors and incidence estimation.
    Sadowski EA; Bennett LK; Chan MR; Wentland AL; Garrett AL; Garrett RW; Djamali A
    Radiology; 2007 Apr; 243(1):148-57. PubMed ID: 17267695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.